STOCK TITAN

RNVAD Stock Price, News & Analysis

RNVAD

Company Description

RNVAD (OTC: RNVAD) is a publicly traded diagnostics & research company in the Healthcare sector. The company has a market capitalization of $20.8K.

RNVAD stock has declined 92.8% over the past year.

This page provides a comprehensive overview of RNVAD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
-92.8%
Performance 1 year
$20.8K

RNVAD (RNVAD) stock. Over the past 12 months, the stock has lost 92.8%. At a market capitalization of $20.8K, RNVAD is classified as a micro-cap stock with approximately 2.9M shares outstanding.

Latest News

RNVAD has 2 recent news articles. Key topics include stock split. View all RNVAD news →

SEC Filings

No SEC filings available for RNVAD.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

RNVAD Company Profile & Sector Positioning

RNVAD (RNVAD) operates in the Diagnostics & Research industry within the broader Healthcare sector.

Investors comparing RNVAD often look at related companies in the same sector, including Inotiv Inc (NOTV), Precipio Inc (PRPO), Prophase Labs Inc (PRPH), Ispecimen Inc. (ISPC), and Advanced Biomed Inc. (ADVB). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate RNVAD's relative position within its industry.

Frequently Asked Questions

What is the market cap of RNVAD (RNVAD)?

The market cap of RNVAD (RNVAD) is approximately 20.8K. Learn more about what market capitalization means .